Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1272 FosaprepitantSummary: Neurokinin-1 antagonist
- B2145 Fosaprepitant dimeglumine saltTarget: Neurokinin receptorSummary: Neurokinin-1 antagonist
- B2099 HaloperidolSummary: Antipsychotic drug
- B1242 Haloperidol hydrochlorideSummary: Antipsychotic drug
- B2235 ClozapineTarget: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 ReceptorsSummary: 5-HT receptor antagonist
- B2240 OlanzapineTarget: 5-HT2 Receptors|D2 ReceptorsSummary: Antagonist of 5-HT2A and dopamine D2 receptors
- B1479 AmisulprideSummary: Dopamine D2/D3 receptor antagonist
- B2232 AripiprazoleTarget: 5-HT1 ReceptorsSummary: 5-HT receptor partial agonist
- B1199 TandospironeSummary: Anxiolytic and antidepressant reagent
- B1570 CiproxifanSummary: Histamine H3-receptor antagonist